Marylane Sousa

Dr. Marylane Sousa


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Enzyme and Microbial Technology
Verified
Journal Article
Closed access
MSMarylane Sousa
Marylane Sousa
BGBárbara Silva Gurgel
Bárbara Silva Gurgel
BPBenevides Pessela
Benevides Pessela
Luciana Rocha Barros GoncalvesLuciana Rocha Barros Goncalves
Luciana Rocha Barros Goncalves

15 November 2018 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
MSMarylane Sousa
Marylane Sousa
VMVania Melo
Vania Melo
DHDenise C Hissa
Denise C Hissa
RMRicardo Manzo
Ricardo Manzo
EMEnrique J Mammarella
Enrique J Mammarella
Luciana Rocha Barros GoncalvesLuciana Rocha Barros Goncalves
Luciana Rocha Barros Goncalves

6 December 2017 in Molecules
Verified
Journal Article
Open access
PDF file
MSMarylane Sousa
Marylane Sousa
RMRicardo Manzo
Ricardo Manzo
JGJosé Luis García
José Luis García
EMEnrique J. Mammarella
Enrique J. Mammarella
Luciana Rocha Barros GoncalvesLuciana Rocha Barros Goncalves
Luciana Rocha Barros Goncalves
BPBenevides Pessela
Benevides Pessela
L-Arabinose isomerase (EC 5.3.1.4) (l-AI) from Enterococcus faecium DBFIQ E36 was overproduced in Escherichia coli by designing a codon-optimized synthetic araA gene. Using this optimized gene, two N- and C-terminal His-tagged-l-AI proteins were produced. The cloning of the two chimeric genes into regulated expression vectors resulted in the production of high amounts of recombinant N-His-l-AI and C-His-l-AI in soluble and active forms. Both His-tagged enzymes were purified in a single step through metal-affinity chromatography and showed different kinetic and structural characteristics. Analytical ultracentrifugation revealed that C-His-l-AI was preferentially hexameric in solution, whereas N-His-l-AI was mainly monomeric. The specific activity of the N-His-l-AI at acidic pH was higher than that of C-His-l-AI and showed a maximum bioconversion yield of 26% at 50 °C for d-tagatose biosynthesis, with Km and Vmax parameters of 252 mM and 0.092 U mg−1, respectively. However, C-His-l-AI was more active and stable at alkaline pH than N-His-l-AI. N-His-l-AI follows a Michaelis-Menten kinetic, whereas C-His-l-AI fitted to a sigmoidal saturation curve.

30 January 2023 in Catalysts
Verified
Journal Article
Open access
PDF file
LFLucas A. de Freitas
Lucas A. de Freitas
MSMarylane Sousa
Marylane Sousa
LRLaiza Ribeiro
Laiza Ribeiro
ÍFÍtalo W. L. de França
Ítalo W. L. de França
Luciana Rocha Barros GoncalvesLuciana Rocha Barros Goncalves
Luciana Rocha Barros Goncalves
β-galactosidase is an enzyme capable of hydrolysing lactose, used in various branches of industry, mainly the food industry. As the efficient industrial use of enzymes depends on their reuse, it is necessary to find an effective method for immobilisation, maintaining high activity and stability. The present work proposes cross-linked magnetic cross-linked enzyme aggregates (mCLEAs) to prepare heterogeneous biocatalysts of β-galactosidase. Different concentrations of glutaraldehyde (0.6%, 1.0%, 1.5%), used as a cross-linking agent, were studied. The use of dextran-aldehyde as an alternative cross-linking agent was also evaluated. The mCLEAs presented increased recovered activity directly related to the concentration of glutaraldehyde. Modifications to the protocol to prepare mCLEAs with glutaraldehyde, adding a competitive inhibitor or polymer coating, have not been effective in increasing the recovered activity of the heterogeneous biocatalysts or its thermal stability. The biocatalyst prepared using dextran-aldehyde presented 73.6% recovered activity, aside from substrate affinity equivalent to the free enzyme. The thermal stability at 60 °C was higher for the biocatalyst prepared with glutaraldehyde (mCLEA-GLU-1.5) than the one produced with dextran-aldehyde (mCLEA-DEX), and the opposite happened at 50 °C. Results obtained for lactose hydrolysis, the use of its product to produce a rare sugar (D-tagatose) and operational and storage stability indicate that heterogeneous biocatalysts have adequate characteristics for industrial use.